Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

BUY
$0.91 - $2.34 $59 - $152
65 New
65 $0
Q1 2022

Apr 20, 2022

SELL
$1.98 - $5.01 $128 - $325
-65 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$4.58 - $17.14 $297 - $1,114
65 New
65 $0

Others Institutions Holding BTTX

# of Institutions
1
Shares Held
3K
Call Options Held
0
Put Options Held
0

About Better Therapeutics, Inc.


  • Ticker BTTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,743,000
  • Description
  • Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...
More about BTTX
Track This Portfolio

Track Psi Advisors, LLC Portfolio

Follow Psi Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Psi Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Psi Advisors, LLC with notifications on news.